The recently approved medication, Mounjaro, is sparking considerable buzz within the medical community as a possible advancement for managing Adult-Onset Metabolic Disorder. Unlike some existing approaches, Mounjaro utilizes a dual approach, targeting both GLP-1 receptors and the glucose-dependent receptor, leading to better glycemic regulation … Read More